Home
MTNB
MTNB News

Latest Matinas Biopharma Holdings Inc. (MTNB) News on August 17, 2025

MT Newswires

5 months ago

Matinas BioPharma Chairman Eric Ende Resigns

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

GlobeNewswire

5 months ago

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors

GlobeNewswire

6 months ago

Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors

Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair

GlobeNewswire

6 months ago

Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair

Matinas BioPharma Receives NYSE Noncompliance Notice

GlobeNewswire

7 months ago

Matinas BioPharma Receives NYSE Noncompliance Notice

MT Newswires

10 months ago

Top Midday Decliners

Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction

GlobeNewswire

10 months ago

Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction

Highbridge Capital Management's Strategic Acquisition in Matinas BioPharma

GuruFocus.com

10 months ago

Highbridge Capital Management's Strategic Acquisition in Matinas BioPharma

Upcoming Stock Splits This Week (September 2 to September 6) – Stay Invested

TipRanks

a year ago

Upcoming Stock Splits This Week (September 2 to September 6) – Stay Invested

Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire

a year ago

Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update

Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024

GlobeNewswire

a year ago

Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024

Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program

GlobeNewswire

a year ago

Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program

Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin

GlobeNewswire

a year ago

Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

GuruFocus.com

a year ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

Energy Global

a year ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

USA TODAY

a year ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Business Wire

a year ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Business Wire

a year ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

SEALSQ to Launch Two New Quantum Resistant Chips

GlobeNewswire

a year ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Reuters

a year ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

GlobeNewswire

a year ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

a year ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

a year ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

a year ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

a year ago

3 Mistakes That Can Get Your Costco Membership Canceled

New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024

GlobeNewswire

a year ago

New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024

Thomson Reuters StreetEvents

a year ago

Q1 2024 Matinas BioPharma Holdings Inc Earnings Call

Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q1 2024 Earnings Call Transcript

Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire

a year ago

Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update

Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ASGCT Annual Meeting

GlobeNewswire

a year ago

Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ASGCT Annual Meeting

Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024

GlobeNewswire

a year ago

Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024

In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy

GlobeNewswire

a year ago

In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy

Matinas BioPharma Prices $10 Million Registered Direct Offering

GlobeNewswire

a year ago

Matinas BioPharma Prices $10 Million Registered Direct Offering

Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q4 2023 Matinas BioPharma Holdings Inc Earnings Call

Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update

GlobeNewswire

a year ago

Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update

Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation

GlobeNewswire

a year ago

Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation

Why Is Fungal Infections-Focused Matinas BioPharma Stock Trading Higher On Friday?

Benzinga

a year ago

Why Is Fungal Infections-Focused Matinas BioPharma Stock Trading Higher On Friday?

Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response

GlobeNewswire

a year ago

Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response

Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards

GlobeNewswire

a year ago

Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards

Matinas BioPharma Provides Positive Outcomes Update on the MAT2203 Compassionate/Expanded Use Access Program, Including Multiple Patients with Complete Clinical Resolution

GlobeNewswire

a year ago

Matinas BioPharma Provides Positive Outcomes Update on the MAT2203 Compassionate/Expanded Use Access Program, Including Multiple Patients with Complete Clinical Resolution

Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis

GlobeNewswire

a year ago

Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis

U.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo Classification Request for Marketing Authorization of ProSense® for Early-Stage Breast Cancer

PR Newswire

2 years ago

U.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo Classification Request for Marketing Authorization of ProSense® for Early-Stage Breast Cancer

AmeriServ Financial's (NASDAQ:ASRV) Dividend Will Be $0.03

Simply Wall St.

2 years ago

AmeriServ Financial's (NASDAQ:ASRV) Dividend Will Be $0.03

Investors Met With Slowing Returns on Capital At PermRock Royalty Trust (NYSE:PRT)

Simply Wall St.

2 years ago

Investors Met With Slowing Returns on Capital At PermRock Royalty Trust (NYSE:PRT)

Business Wire

2 years ago

Intevac to Announce Fourth Quarter and Fiscal Year 2023 Results on February 5th

Down -72.39% in 4 Weeks, Here's Why You Should You Buy the Dip in AlloVir, Inc. (ALVR)

Zacks

2 years ago

Down -72.39% in 4 Weeks, Here's Why You Should You Buy the Dip in AlloVir, Inc. (ALVR)

Associated Press Finance

2 years ago

Concrete Pumping: Fiscal Q4 Earnings Snapshot

Concrete Pumping Holdings Reports Strong Fourth Quarter and Fiscal Year 2023 Results, Provides Financial Outlook for Fiscal Year 2024

GlobeNewswire

2 years ago

Concrete Pumping Holdings Reports Strong Fourth Quarter and Fiscal Year 2023 Results, Provides Financial Outlook for Fiscal Year 2024

Should Value Investors Buy OP Bancorp (OPBK) Stock?

Zacks

2 years ago

Should Value Investors Buy OP Bancorp (OPBK) Stock?

Arqit announces reseller agreement with Phalanx

GlobeNewswire

2 years ago

Arqit announces reseller agreement with Phalanx

Merck (MRK) Begins Pivotal Studies on Four Cancer Candidates

Zacks

2 years ago

Merck (MRK) Begins Pivotal Studies on Four Cancer Candidates

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

PR Newswire

2 years ago

CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California

Alico, Inc. to Attend the 2024 ICR Conference in Orlando, Florida

GlobeNewswire

2 years ago

Alico, Inc. to Attend the 2024 ICR Conference in Orlando, Florida

The 7 Best Monthly Dividend Stocks: 2024 Edition

InvestorPlace

2 years ago

The 7 Best Monthly Dividend Stocks: 2024 Edition

Keros Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire

2 years ago

Keros Therapeutics Announces Proposed Public Offering of Common Stock

Great week for NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) institutional investors after losing 75% over the previous year

Simply Wall St.

2 years ago

Great week for NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) institutional investors after losing 75% over the previous year

Matinas BioPharma to Present at Biotech Showcase 2024

GlobeNewswire

2 years ago

Matinas BioPharma to Present at Biotech Showcase 2024

Intevac Announces Successful Qualification of TRIO™ System

Business Wire

2 years ago

Intevac Announces Successful Qualification of TRIO™ System

Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients

PR Newswire

2 years ago

Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients

Here's What Profire Energy's (NASDAQ:PFIE) Strong Returns On Capital Mean

Simply Wall St.

2 years ago

Here's What Profire Energy's (NASDAQ:PFIE) Strong Returns On Capital Mean

Should You Invest in Aurora Cannabis Stock in 2024?

Motley Fool

2 years ago

Should You Invest in Aurora Cannabis Stock in 2024?

TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion Plans

GlobeNewswire

2 years ago

TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion Plans

Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides

GlobeNewswire

2 years ago

Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides

Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers

GlobeNewswire

2 years ago

Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers

Matinas BioPharma Provides Update to MAT2203 Regulatory and Development Pathway Following Feedback from FDA

GlobeNewswire

2 years ago

Matinas BioPharma Provides Update to MAT2203 Regulatory and Development Pathway Following Feedback from FDA

Immix Biopharma Announces Dr. Marko Radic, Autoimmune CAR-T Pioneer and Associate Professor at the University of Tennessee Health Science Center, Joins Scientific Advisory Board

GlobeNewswire

2 years ago

Immix Biopharma Announces Dr. Marko Radic, Autoimmune CAR-T Pioneer and Associate Professor at the University of Tennessee Health Science Center, Joins Scientific Advisory Board

Veru Announces Pricing of Public Offering of Common Stock

GlobeNewswire

2 years ago

Veru Announces Pricing of Public Offering of Common Stock

Nektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue?

Zacks

2 years ago

Nektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue?

Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2024

PR Newswire

2 years ago

Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2024

Business Wire

2 years ago

Certain Morgan Stanley Closed-End Funds Declare Year-End Dividends

PureCycle Resumes Pellet Production at Ironton Purification Facility

ACCESSWIRE

2 years ago

PureCycle Resumes Pellet Production at Ironton Purification Facility

PureCycle Appoints Jeff Fieler as Interim CFO

ACCESSWIRE

2 years ago

PureCycle Appoints Jeff Fieler as Interim CFO

Here's Why InflaRx N.V. (IFRX) Looks Ripe for Bottom Fishing

Zacks

2 years ago

Here's Why InflaRx N.V. (IFRX) Looks Ripe for Bottom Fishing

Fenix 360 Pte Ltd. To Go Public Through Merger With DUET Acquisition Corp. to Create a Global Social Media Platform

GlobeNewswire

2 years ago

Fenix 360 Pte Ltd. To Go Public Through Merger With DUET Acquisition Corp. to Create a Global Social Media Platform

Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023

GlobeNewswire

2 years ago

Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023

Identiv’s FIDO2 Security Keys Win 2023 American Security Today ASTORS Award for Best Cybersecurity Solution

Business Wire

2 years ago

Identiv’s FIDO2 Security Keys Win 2023 American Security Today ASTORS Award for Best Cybersecurity Solution

Those who invested in Where Food Comes From (NASDAQ:WFCF) five years ago are up 73%

Simply Wall St.

2 years ago

Those who invested in Where Food Comes From (NASDAQ:WFCF) five years ago are up 73%

Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Spruce Power Holding Corp Earnings Call

Insiders Give Up US$60k As Eos Energy Enterprises Stock Drops To US$1.36

Simply Wall St.

2 years ago

Insiders Give Up US$60k As Eos Energy Enterprises Stock Drops To US$1.36

Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights

GlobeNewswire

2 years ago

Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Spruce Power Announces Record Revenue in Third Quarter 2023 Earnings Results

Business Wire

2 years ago

Spruce Power Announces Record Revenue in Third Quarter 2023 Earnings Results

12 Best Day Trading Stocks To Buy

Insider Monkey

2 years ago

12 Best Day Trading Stocks To Buy

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Matinas BioPharma Holdings Inc Earnings Call

Matinas BioPharma Holdings Inc (MTNB) Reports Q3 2023 Financial Results and Business Progress

GuruFocus.com

2 years ago

Matinas BioPharma Holdings Inc (MTNB) Reports Q3 2023 Financial Results and Business Progress

Matinas BioPharma Reports Third Quarter 2023 Financial Results and Provides a Business Update

GlobeNewswire

2 years ago

Matinas BioPharma Reports Third Quarter 2023 Financial Results and Provides a Business Update

Down -13.69% in 4 Weeks, Here's Why Amplify Energy (AMPY) Looks Ripe for a Turnaround

Zacks

2 years ago

Down -13.69% in 4 Weeks, Here's Why Amplify Energy (AMPY) Looks Ripe for a Turnaround

Sunlands Technology Group to Report Third Quarter 2023 Financial Results on Wednesday November 22, 2023

GlobeNewswire

2 years ago

Sunlands Technology Group to Report Third Quarter 2023 Financial Results on Wednesday November 22, 2023

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Amplify Energy Corp Earnings Call

Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC

CNW Group

2 years ago

Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC

Share on Social Networks: